tert-Butyl ((1R,3S)-rel-3-hydroxy-3-methylcyclopentyl)carbamate

Catalog No. :
ACAEBL764
CAS No. :
1352343-65-7
Molecular Formula :
C11H21NO3
Molecular Weight :
215.29

IUPAC Name:tert-butyl ((1R,3S)-3-hydroxy-3-methylcyclopentyl)carbamate

tert-Butyl ((1R,3S)-rel-3-hydroxy-3-methylcyclopentyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$434.00Login to see priceInquiryInquiry
250mg98%$615.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl ((1R,3S)-rel-3-hydroxy-3-methylcyclopentyl)carbamate
IUPAC Nametert-butyl ((1R,3S)-3-hydroxy-3-methylcyclopentyl)carbamate
MDL No.MFCD28987737
Molecular FormulaC11H21NO3
Molecular Weight215.29
SMILESO=C(OC(C)(C)C)N[C@H]1C[C@@](C)(O)CC1
InChI KeyUYJVGPICOQDHIC-KCJUWKMLSA-N
Synonymrel-tert-butyl ((1R,3S)-3-hydroxy-3-methylcyclopentyl)carbamate;Carbamic acid, N-[(1R,3S)-3-hydroxy-3-methylcyclopentyl]-, 1,1-dimethylethyl ester, rel-;tert-butyl N-[cis-3-hydroxy-3-methyl-cyclopentyl]carbamate;cis-3-(Boc-amino)-1-methylcyclopentanol
CAS No.1352343-65-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P280-P304+P340-P305+P351+P338

Synthetic Route by SureRoute

1. ACAEBL764 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGEZI186 route compound structure diagram
    ACGEZI186225641-86-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAEBL764 route product structure diagram
    ACAEBL7641352343-65-7
Inquiry

2. ACAEBL764 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAEBL764 route product structure diagram
    ACAEBL7641352343-65-7
Inquiry

Comments (0)